Bundle of expertise: YUMAB and ISAR Bioscience are working on an innovative transferrin receptor antibody platform for the transport of therapeutics across the blood-brain barrier

YUMBAB and ISAR are bundling their complementary competencies and developing a novel platform for the transport of therapeutics across the blood-brain barrier.

The post  Gebündelte Kompetenzen: YUMAB und ISAR Bioscience arbeiten an einer innovativen Transferrinrezeptor-Antikörperplattform für den Transport von Therapeutika über die Blut-Hirn-Schranke  appeared first on  Niedersachsen Next .

Comments